Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

HIV vaccine vCP1521 - Sanofi

Next Previous
X
Search
Drug Profile

HIV vaccine vCP1521 - Sanofi

Alternative Names: ALVAC-HIV-vCP1521; Aventis Pasteur live recombinant ALVAC-HIV (vCP1521) priming vaccine + VaxGen gp120 B/E (AIDSVAX B/E) boosting vaccine; vCP1521

Latest Information Update: 04 Apr 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator sanofi pasteur
  • Developer Sanofi Pasteur
  • Class AIDS vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No

Highest Development Phases

  • Phase III HIV-1 infections

Most Recent Events

  • 08 Mar 2020 Immunogenicity data from a phase III trial in HIV-Unaffected volunteers presented at the 27th Conference on Retroviruses and Opportunistic Infections (CROI-2020)
  • 04 Mar 2019 Pooled immunogenicity data from the RV305 and RV306 phase II trials in HIV-1 infections presented at the 26th Conference on Retroviruses and Opportunistic Infections (CROI-2019)
  • 31 Jul 2018 Sanofi announces intention to submit regulatory application for HIV 1 infections in 2022

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top